Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Australia (1)
Austria (6)
Belgium (15)
Burkina Faso (1)
Czech Republic (2)
Denmark (7)
Finland (8)
France (17)
Gabon (1)
Germany (23)
Greece (1)
Hungary (1)
Ireland (3)
Israel (1)
Italy (15)
Luxembourg (6)
Netherlands (22)
Norway (1)
Poland (1)
Portugal (1)
Senegal (1)
Slovenia (2)
Spain (13)
Sweden (13)
Switzerland (12)
United Kingdom (28)
United States (9)

Content Type

Project (26)
Programme (40)

Language

English (64)

Advanced search

Results 1 - 10 of 66
Results/page:
12 3 4 5 6 7 > 
Amyloid imaging to Prevent Alzheimer’s Disease
ID: 115952
Start date: 2016-12-08, End date: 2021-09-30
Beta-amyloid (β-amyloid) deposition is considered to be a necessary - but not sufficient - step on the path towards Alzheimer’s disease (AD). Depiction of brain β-amyloid in vivo can support an early diagnosis, and even provide an opportunity for consider secondary...
Programme: H2020-EU.3.1.7.
Record Number: 209458
Last updated on: 2017-03-27
Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes.
ID: 115797
Start date: 2015-12-10, End date: 2022-10-31
Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findings from in vitro and animal models into effective clinical interventions. INNODIA aims to achieve a break-through in the way in which we...
Programme: H2020-EU.3.1.7.4.
Record Number: 209863
Last updated on: 2017-03-27
Mobile Filovirus Nucleic Acid Test
ID: 115848
Start date: 2015-02-01, End date: 2017-04-30
We are proposing to develop a molecular assay for the safe, rapid, specific and sensitive detection of Ebola Virus Infection in capillary (or venous) blood samples combining ALTONA’s Pan-filo screening IVD test with the existing Alere™ q point of care molecular diagnostics...
Programme: H2020-EU.3.1.7.13.
Record Number: 209448
Last updated on: 2017-06-01
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
ID: 115902
Start date: 2016-04-01, End date: 2021-03-31
Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, adverse events and disease course. This can be inefficient and cumbersome – clinic visits may be too infrequent to identify individuals at...
Programme: H2020-EU.3.1.7.13.
Record Number: 209453
Last updated on: 2017-05-23
PERtussIS COrrelates of Protection Europe
ID: 115910
Start date: 2016-08-10, End date: 2021-02-28
Pertussis vaccines have been very successful in reducing the global burden of pertussis-related disease. However, in the last decade there has been a rise in pertussis incidence, particularly in vaccinated adolescents and adults in industrialized countries. The increased...
Programme: H2020-EU.3.1.7.12.
Record Number: 209454
Last updated on: 2017-03-27
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes
ID: 115890
Start date: 2015-09-03, End date: 2017-12-31
Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major adaptations to current paradigms of bringing medicines to patients are required in order to realize that potential and to address important...
Programme: H2020-EU.3.1.7.13.
Record Number: 209455
Last updated on: 2017-03-27
Patient Preferences in benefit risk assessments during the drug life cycle
ID: 115966
Start date: 2016-11-16, End date: 2021-09-30
The PREFER project will deliver an overview and evaluation of preference elicitation methods to be applied in the entire drug life cycle, i.e. in the early stages of identifying medical needs, in clinical testing, to guide decisions on reimbursement and to make decisions on...
Programme: H2020-EU.3.1.7.
Record Number: 209460
Last updated on: 2017-08-05
Vaccine lot to Vaccine lot comparison by consistancy testing
ID: 115924
Start date: 2016-04-28, End date: 2021-02-28
Lot release testing of established vaccines relies on using animal models. Many of these models were developed decades ago and reflect the level of product knowledge, production technology and quality management in those days. Current production techniques are optimised...
Programme: H2020-EU.3.1.7.12.
Record Number: 209456
Last updated on: 2017-07-03
Models Of Patient Engagement for Alzheimer’s Disease
ID: 115985
Start date: 2016-12-08, End date: 2019-11-30
The MOPEAD consortium has proposed a programme of work carefully aligned to the objectives of IMI2 Call to deliver a step-change in AD-related patient engagement (PE) strategies and a paradigm shift in early stage care. It aims to improve patient engagement in two categories:...
Programme: H2020-EU.3.1.7.
Record Number: 209465
Last updated on: 2017-03-27
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
ID: 115842
Start date: 2015-06-17, End date: 2018-02-28
The proposal, VSV-EBOVAC, directly addresses the topic 1 of the IMI2 call on Ebola by supporting the clinical development of a highly promising new Ebola vaccine candidate, the vesicular stomatitis virus (VSV)‐ vectored Zaire Ebola vaccine (VSV-ZEBOV). In non-human primates...
Programme: H2020-EU.3.1.7.13.
Record Number: 209443
Last updated on: 2017-06-10
12 3 4 5 6 7 > 
List retrieved on: 2017-11-22
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top